Developing Cell Therapies: Enabling cost prediction by value systems modeling to manage developmental risk. (2013)
Attributed to:
EPSRC Centre for Innovative Manufacturing in Regenerative Medicine
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.5912/jcb585
Publication URI: http://dx.doi.org/10.5912/jcb585
Type: Journal Article/Review
Parent Publication: Journal of Commercial Biotechnology
Issue: 2